Gland Pharma Ltd

NSE: GLAND · BSE: 543245 · Pharmaceuticals & Biotechnology · 61 announcements

Gland Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹3,263.90
Market cap: ₹53,858 Cr
Revenue (annual): ₹6,431 Cr
Net profit (annual): ₹1,027 Cr
P/E (TTM): 43.6×Sector 43.8×
Promoter holding: 45.75%-6.02% QoQ
FII holding: 10.36%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

6 Apr 2026 12:15 IST BSE

Gland Pharma Management Change

Gland Pharma Limited has appointed Mr. Prasadha Rao Lysetti as Sr. Vice-President (Head - Operations), effective April 06, 2026. With over 25 years of pharmaceutical operations experience, his leadership is expected to drive operational efficiency and quality-centric manufacturing for the company.

Open announcement → Read the filing ↗

Gland Pharma Ltd by type

Annual General Meeting 9
Management Change 8
Earnings Call 7
Business Update 4
Other Announcement 4
Employee Stock Options 4
Board Meeting Outcome 4
Financial Results 3
Legal & Regulatory 3
Results Update 2
Board Meeting Date 2
Acquisition 2
Promoter Selling 2
Capital Structure Change 2